26.08.2017
Get funding for innovation partnerships to digitalize biopharmaceutical R&D!
Advancing precision medicine in the digital age requires solutions developed in the IT and software sector, e.g. big data, machine learning, IT security, data protection, and cross-enterprise collaboration.
The PERMIDES project aims at bringing together SMEs (micro, small and medium-sized enterprises) from the biopharmaceutical and IT sector to advance precision medicine through the development of novel digital solutions along the biopharma value chain.
Biopharma SMEs participating in the innovation projects can increase competitiveness and benefit from an innovation voucher scheme that will provide up to EUR 60,000 per SME. Besides that Travel Vouchers up to EUR 2000,- are available (see: „Tirol auf der conhIT“).
Information on SME benefits, important dates, project funding, partners and contact details can be found at the project website http://permides.eu.
Join us also at Digital Health Forum Innsbruck on October 2nd, 2017!
PERMIDES - Open Call for Proposals for Financial Support
Publication of PERMIDES Call: March 15th, 2017
Evaluation Deadlines: May 15th & October 10th, 2017
Time from application to project initiation: Up to 3 months
Maximum funding
Biopharma SMEs can avail benefits from this call for obtaining vouchers up to a maximum of EUR 60,000. IT SMEs can collaborate with various biopharma SMEs in multiple projects, and are not affected by EUR 60,000 limit. Please note that biopharma SMEs are the beneficiaries of the innovation projects and the costs involved in providing the services by IT SMEs will be funded and paid to IT SMEs by PERMIDES.
Maximum duration of the innovation projects: 6 months.
All funded projects finalized by: June 15th, 2018.
Web address for proposal submissions: http://permides.eu/apply-now
Scope
Proposals should address innovation barriers and challenges of the biopharmaceutical value chain in the area of personalized medicine by means of digitalization solutions.
Target group
The voucher funding scheme of PERMIDES is aimed at SMEs from the biopharmaceutical sector developing novel personalized medicine products and solutions (e.g. biotech/medtech companies, diagnostic companies, CROs, biobank companies, bioinformatic companies). Only biopharma SMEs, together with IT SMEs, according to EU definition and established in one of the EU Member States or Associated Countries can submit the proposals for funding provided by PERMIDES. To be eligible for funding, project teams need to consist of one biopharma SME as main applicant/beneficiary and at least one IT SME as service provider. Potential project team partners can be found via the PERMIDES platform offering the need-vs-expertise-based matchmaking of companies from the biopharmaceutical and IT sector.
Evaluation criteria
Proposals will be reviewed by a panel of PERMIDES consortium members and external experts based on the following criteria: Innovation Level, Technical Feasibility, Resource Capacities, Partner Competence, Fitness to Industry Needs.
Contact
Simon Schnaiter, PhD
Project Management
Mobile. +43 676 823129229 | Fax. +43 512 576523-301
simon.schnaiter@oncotyrol.at
www.oncotyrol.at